Medical diagnosis

SansWrite Selected to Modernize Inspection and Auditing Process for Ohio Mental Health and Addiction Services

Retrieved on:

Mercredi, avril 17, 2024

Medical diagnosis, Health, Computer, Mental health, Microsoft, Data collection

CINCINNATI, April 17, 2024 (GLOBE NEWSWIRE) -- Outlier Technologies, Inc. today announced it was selected by the Ohio Department of Mental Health and Addiction Services (OhioMHAS) to automate the agency’s survey and inspection processes using the SansWrite Compliance Measurement and Monitoring Platform.

Key Points:

CINCINNATI, April 17, 2024 (GLOBE NEWSWIRE) -- Outlier Technologies, Inc. today announced it was selected by the Ohio Department of Mental Health and Addiction Services (OhioMHAS) to automate the agency’s survey and inspection processes using the SansWrite Compliance Measurement and Monitoring Platform.
The SansWrite Software-as-a-Service platform automates the inspection process for OhioMHAS inspectors and service providers and empowers them with data to improve the quality of mental health and addiction services.
OhioMHAS’ legacy survey and inspection process made it difficult to keep pace with the growing demand for mental health and addiction services across the state.
SansWrite streamlines administrative tasks associated with maintaining compliance so Mental Health and Substance Abuse providers can focus on patient care.

Recovery Centers of America Achieves Strong Outcomes from Innovative Evidence-Based Care Model for Addiction Treatment

Retrieved on:

Mercredi, avril 10, 2024

Addiction, RCA, MAT, Medical diagnosis, Insurance, Substance use disorder, Research, DBT, Medication, Patient, Mental health, Patient satisfaction, Dialectical behavior therapy, NIAAA, Hospital

Fresh Start (Pathway 2): For returning/relapse patients, focuses on addressing gaps in previous recovery experience and identifying top triggers.

Key Points:

Fresh Start (Pathway 2): For returning/relapse patients, focuses on addressing gaps in previous recovery experience and identifying top triggers.
New data shows that the outcomes of RCA’s model is surpassing national standards and other recovery centers, including:
RCA’s readmission rates are below national expectations.
"RCA's evidence-based care model represents a distinctive, innovative, and patient-centered approach to treating addiction and fostering lasting recovery," said Brett Cohen, CEO of RCA.
For more information about RCA’s care model and the new findings about its success, please visit Recovery Centers of America .

Dr. Ashish S. Patel Named Physician-in-Chief at Phoenix Children's

Retrieved on:

Lundi, avril 15, 2024

Accreditation Council, Education, University, Graduate medical education, Gastroenterology, Crohn's disease, Mentorship, Research, ACGME, Nursing, Family, Physician, Medicine, Accreditation, Child, MBA, Medical diagnosis

PHOENIX, April 15, 2024 /PRNewswire/ -- Phoenix Children's today announced the appointment of Ashish S. Patel, MD, as physician-in-chief of the rapidly expanding health system.

Key Points:

PHOENIX, April 15, 2024 /PRNewswire/ -- Phoenix Children's today announced the appointment of Ashish S. Patel, MD , as physician-in-chief of the rapidly expanding health system.
Beyond his clinical responsibilities, Dr. Patel is now part of the health system's Executive Physician Leadership team and the Phoenix Children's Medical Group Governance Council.
Prior to his promotion to physician-in-chief, Dr. Patel served as division chief of gastroenterology , hepatology and nutrition at Phoenix Children's for four years.
A search is currently underway to fill Dr. Patel's vacated role of division chief of gastroenterology, hepatology and nutrition at Phoenix Children's.

Gedeon Richter: Cariprazine shows effectiveness in the treatment for dual disorder

Retrieved on:

Lundi, avril 15, 2024

Crave, Disorder, Congress, European Psychiatric Association, Gedeon Richter, Poster, DSM-IV codes, Cariprazine, Science, Patient, Scott Richter, Observational study, Medical diagnosis, Caregiver, Anxiety, Mood, Pharmaceutical industry

The scientific posters proved that cariprazine might be an appropriate treatment not only for early and late-stage schizophrenia, but also for the difficult-to-treat dual disorder (schizophrenia and comorbid substance use disorder).

Key Points:

The scientific posters proved that cariprazine might be an appropriate treatment not only for early and late-stage schizophrenia, but also for the difficult-to-treat dual disorder (schizophrenia and comorbid substance use disorder).
Furthermore, a new transdiagnostic tool for quantifying, and visualizing symptom severity and functional disability of patients with different psychiatric conditions was presented.
A special Gedeon Richter publication, the "Candid Book" was also introduced by the authors, which contains useful, everyday suggestions for the caregivers of patients.
The final poster was providing information on the potential of cariprazine in dual disorder, the co-occurrence of a major psychiatric disorder and comorbid substance use disorder.

National Experts in Psychology, Addiction Counseling, and Clinical Services Join Kyros' Inaugural Independent Clinical Advisory Board

Retrieved on:

Mardi, février 20, 2024

MINNEAPOLIS, Feb. 20, 2024 /PRNewswire/ -- In a significant move to strengthen its commitment to addressing substance use disorders and enhancing community recovery efforts, Kyros is excited to announce the establishment of its Independent Clinical Advisory Board and the following appointments:

Key Points:

The Clinical Advisory Board's mission is to independently advise Kyros leadership on improving care and outcomes for individuals with substance use disorders.
It does this by providing evidence-based recommendations, promoting collaboration among stakeholders, and driving continuous improvement in recovery care services.
Professor Helwig is the author of 10 open-source statistical software packages, which have amassed over 1,000,000 downloads in recent years.
Their profound expertise will play a pivotal role in tackling urgent issues such as the opioid epidemic, dual diagnosis, and the need for comprehensive recovery support services."

Orlando Health and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital to Serve Greater Orlando Area

Retrieved on:

Jeudi, février 15, 2024

Orlando Health and Acadia Healthcare today held a ceremony to celebrate the start of construction on a previously announced 144-bed behavioral health hospital that will expand access to critical mental health services in the Orlando metro area.

Key Points:

Orlando Health and Acadia Healthcare today held a ceremony to celebrate the start of construction on a previously announced 144-bed behavioral health hospital that will expand access to critical mental health services in the Orlando metro area.
View the full release here: https://www.businesswire.com/news/home/20240215860586/en/
Orlando Health and Acadia Healthcare Break Ground on Construction of a New Behavioral Health Hospital in Apopka, Florida, with an anticipated opening in Spring 2025.
“This hospital will expand Orlando Health’s existing capabilities and provide greater access to life-saving behavioral health services,” Chris Hunter, Chief Executive Officer of Acadia Healthcare.
This hospital will extend Orlando Health’s legacy of providing quality behavioral health services to their patients.”
Once the new hospital is fully operational, Orlando Health will transfer all inpatient behavioral health services from its South Seminole Hospital Campus.

Global Terahertz Radiation System Market Report 2030: Global Expansion of Non-Invasive Diagnostic Approaches and Industrial Testing Methods Boosts Market Growth

Retrieved on:

Jeudi, janvier 18, 2024

Research, Partner, Cancer, Terahertz radiation, Skin, USD, Organization, Medical diagnosis, Region, Diagnosis, Growth, Medical imaging

In a significant development within the field of electromagnetic spectrum technologies, recent research suggests a formidable growth trajectory for the Terahertz Radiation System Market.

Key Points:

In a significant development within the field of electromagnetic spectrum technologies, recent research suggests a formidable growth trajectory for the Terahertz Radiation System Market.
Terahertz radiation, nestled between the microwave and infrared frequencies, has garnered substantial attention owing to its capabilities for material penetration without causing damage, making it imperative for non-invasive industrial testing.
With a trajectory set toward robust growth, the Terahertz Radiation System Market appears replete with opportunities for industries and countries tuning into its potential.
Encompassing types such as imaging devices and spectroscope, and diverse applications from healthcare to military, the global Terahertz Radiation System Market encapsulates a thorough competitive and territorial analysis.

Charles Brown Wins Leadership Excellence Award in Medical Diagnostics and Laboratory Testing

Retrieved on:

Mercredi, décembre 20, 2023

COVID-19, Medical diagnosis, Government, Nursing

Toronto, Ontario, Dec. 20, 2023 (GLOBE NEWSWIRE) -- We are thrilled to announce that Charles Brown, the President and CEO of LifeLabs, has been honoured with the prestigious Leadership Excellence in Medical Diagnostics and Laboratory Testing in the 2023 CEO Healthcare Awards, presented by CEO Today magazine.

Key Points:

Toronto, Ontario, Dec. 20, 2023 (GLOBE NEWSWIRE) -- We are thrilled to announce that Charles Brown, the President and CEO of LifeLabs, has been honoured with the prestigious Leadership Excellence in Medical Diagnostics and Laboratory Testing in the 2023 CEO Healthcare Awards, presented by CEO Today magazine.
This distinguished award celebrates individuals who have demonstrated outstanding leadership, innovative thinking, and profound impact in the healthcare field.
Since assuming the CEO role at LifeLabs, Charles Brown has been unwavering in his commitment to optimizing service delivery, aiming to achieve superior outcomes for our customers and medical professionals.
This award truly reflects the tremendous work they accomplish every day, empowering our customers and communities through medical diagnostics and lab testing."

Beach House Announces New Mental Health Treatment Services

Retrieved on:

Mardi, décembre 12, 2023

Beach House, Factitious disorder, Mental health, Mental, Patient, Knowledge, Medical diagnosis, Substance abuse, MD, COVID, Nursing

JUNO BEACH, Fla., Dec. 12, 2023 /PRNewswire/ -- Beach House Behavioral Health, Inc. ("Beach House" or the "Company"), a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based healthcare private equity firm, announced new mental health treatment services in addition to the comprehensive substance use disorder treatment services that the Company provides.

Key Points:

JUNO BEACH, Fla., Dec. 12, 2023 /PRNewswire/ -- Beach House Behavioral Health, Inc. ("Beach House" or the "Company"), a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based healthcare private equity firm, announced new mental health treatment services in addition to the comprehensive substance use disorder treatment services that the Company provides.
The Beach House team strongly believes there is a significant need for the treatment of mental health conditions in the community both in patients with primary mental health conditions and in those with co-occurring disorders.
Beach House will now also be able to treat patients with primary mental health conditions.
Mark Pundt, MD, CEO of Beach House said, "As a physician it is important for me to lead Beach House in expanding the spectrum of healthcare services we provide to our patients.

Government of Canada Announces Richmond-based 9-8-8 Network partner

Retrieved on:

Lundi, novembre 20, 2023

The Government of Canada is taking steps to help ensure that everyone in Canada has access to suicide prevention resources and other crisis supports—whenever and wherever they need them.

Key Points:

The Government of Canada is taking steps to help ensure that everyone in Canada has access to suicide prevention resources and other crisis supports—whenever and wherever they need them.
In July, the Government of Canada announced an investment of $156 million over three years to the Centre for Addiction and Mental Health (CAMH) for the implementation and operation of 9-8-8: Suicide Crisis Helpline, building on their experience delivering Talk Suicide Canada.
Chief Medical Officer, 9-8-8 and Talk Suicide Canada and Psychiatrist, CAMH
"Suicide does not discriminate; it affects people of all ages and backgrounds across Canada.
If an individual is interested in becoming a responder, they can visit the Talk Suicide Canada website at Volunteer with Talk Suicide Canada or Work with Talk Suicide Canada .